Clinical Trial Update: Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated whether risedronate can prevent periprosthetic bone loss after total hip arthroplasty; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periprosthetic Osteolysis

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Danderyd Hospital | Conditions: Bone Loss | Phase 4 | Status: COMPLETED